Literature DB >> 32938653

Primary haemochromatosis resulting in dilated cardiomyopathy arising out of mutation in HJV gene in Indian patients: a rare scenario.

Abhishek Goyal1, Bishav Mohan2, Kavita Saggar3, Gurpreet Singh Wander2.   

Abstract

Primary haemochromatosis (PH) is a genetic disorder of iron metabolism with multiorgan involvement due to mutations in HFE or more rarely haemojuvelin (HJV) gene. Cardiac involvement results in dilated cardiomyopathy with reduced ejection fraction and progressive heart failure. PH is rarely reported from India and cardiomyopathy due to PH from HJV mutations is thought to be uncommon. We report two families with cardiomyopathy resulting from PH. Diagnosis was suspected on the basis of skin pigmentation, markedly elevated serum ferritin and transferring saturation. Genetic testing revealed a rare mutation in HJV gene in one family. Being a treatable condition, PH should be suspected and investigated in cardiomyopathy patients in Indian subcontinent. If HFE is negative, analysis of non-HFE mutation should always be considered. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  genetics; heart failure

Mesh:

Substances:

Year:  2020        PMID: 32938653      PMCID: PMC7497139          DOI: 10.1136/bcr-2020-235650

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Obscure pathogenesis of primary iron overload in Indians warrants more focused research.

Authors:  Reena Das; Giriraj Ratan Chandak
Journal:  Indian J Gastroenterol       Date:  2011-08-17

2.  Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis.

Authors:  Yongwei Wang; Yali Du; Gang Liu; Shanshan Guo; Bo Hou; Xianyong Jiang; Bing Han; Yanzhong Chang; Guangjun Nie
Journal:  Int J Hematol       Date:  2016-11-28       Impact factor: 2.490

3.  HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.

Authors:  Priyanka Shukla; Sandeep Julka; Eesh Bhatia; Sudeep Shah; Aabha Nagral; Rakesh Aggarwal
Journal:  Natl Med J India       Date:  2006 Jan-Feb       Impact factor: 0.537

4.  Examining the clinical use of hemochromatosis genetic testing.

Authors:  Matthew B Lanktree; Bruce B Lanktree; Guillaume Paré; John S Waye; Bekim Sadikovic; Mark A Crowther
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jan-Feb

5.  Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations.

Authors:  Ajay Duseja; Reena Das; Mohit Nanda; Ashim Das; Gurjeewan Garewal; Yogesh Chawla
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

6.  MR imaging findings of iron overload.

Authors:  Marcony Queiroz-Andrade; Roberto Blasbalg; Cinthia D Ortega; Marco A M Rodstein; Ronaldo H Baroni; Manoel S Rocha; Giovanni G Cerri
Journal:  Radiographics       Date:  2009-10       Impact factor: 5.333

7.  Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India.

Authors:  V Thakur; R C Guptan; A Z Hashmi; P Sakhuja; V Malhotra; S K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2004-01       Impact factor: 4.029

8.  Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India.

Authors:  Barjinderjit Kaur Dhillon; Reena Das; Gurjeewan Garewal; Yogesh Chawla; R K Dhiman; Ashim Das; Ajay Duseja; G R Chandak
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

Review 9.  Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.

Authors:  Antoine N Saliba; Afif R Harb; Ali T Taher
Journal:  J Blood Med       Date:  2015-06-17

10.  Raised serum ferritin concentration in hereditary hyperferritinemia cataract syndrome is not a marker for iron overload.

Authors:  Dan Yin; Vasu Kulhalli; Ann P Walker
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.